Table 1.
Associations supported by meta-analytic evidence
Antecedent | Outcomes | Meta-analytic support |
---|---|---|
PTSD | CVD events | |
Incident CHD | HR= 1.55 (95% CI 1.34–1.79); with adjustment for depression, HR= 1.27 (95% CI 1.08–1.49) Edmondson et al., 2013 |
|
Incident stroke/TIA | RR= 2.36 (95% CI 2.11–2.65) Emdin et al., 2016 |
|
Incident VTE | No | |
Recurrent MI/unstable angina/mortality | RR= 2.0 (95% CI, 1.69–2.37) Edmondson et al., 2013 |
|
Recurrent stroke/TIA | No | |
Mechanisms | ||
Type 2 diabetes | RR = 1.49, 95% CI = 1.17–1.89) Vancampfort et al., 2016 |
|
Metabolic syndrome | OR= RR = 1.82; 95% CI = 1.72 –.92 Rosenbaum et al., 2015 |
|
Blood pressure | Systolic; Unweighted d (SE)= .13 (.07) Diastolic; Unweighted d (SE) = .39 (.21) Buckley et al., 2001 |
|
Inflammation | Greater IL-1β, IL-6, and interferon γ in PTSD Passos et al., 2015 |
|
Cortisol | Unclear Klassens et al., 2012; Morris et al., 2012 |
|
Endothelial dysfunction | No | |
Obesity | OR = 1.35 (95% CI 1.05–1.74) Bartoli et al., 2015 |
|
Smoking | 6/7 studies showed positive associations; ORs ranged 2.04–4.52 Fu et al., 2007 |
|
Sleep | No | |
Medication nonadherence | No | |
ACS | PTSD | 12% screen positive (95% CI, 9%–16%) Edmondson et al., 2013 |
Stroke/TIA | 23% screen positive (95% CI, 16–33%) Edmondson et. al., 2013 |
|
VTE | No |